Overview
assess whether there is a correlation between some factors (age, sex, tumor volume, tumor site, chemotherapy-induced necrosis, radiation and biomarkers) and overall survival (OS) and relapse-free survival (RFS) in patients with Ewing sarcoma.
Identification of reliable prognostic factors could help to identify high-risk patients, which may require a different treatment and follow up.
Eligibility
Inclusion Criteria:
- Male and female patients treated at Rizzoli Orthopaedic Institute between 01/01/1991 and 31/12/2021
- Age ≥ 2 years
- Diagnosis of Ewing Sarcoma
- Patients with available clinical and imaging data
Exclusion Criteria:
- At least one inclusion criterion not met